SUPERNUS PHARMACEUTICALS INC USD0.001 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0LB2 for the last quarter is 143.64 M USD, and it's 12.58% lower compared to the previous quarter. The net income of Q1 24 is 124.00 k USD.